Basic info
Industry
pharmaceutical manufacturing
Sectors
Biotechnology
human purified microbiota
Intestinal disease
GutAlive
Clostridium difficile
Life Science
microbiota
probiotics
anaerobes
microbiome
gut health
LBPs
Health Care
gut microbiota
microbiota isolation
biotherapeutics
Microbiology
microbiota storage
Intestinal Microbiota
Date founded
2016
Funding rounds raised
Total raised
$1.6M
from 1 investors over 1 rounds
M
Microviable Therapeutics SL raised $1.6M on April 19, 2022
Investors: Inmunomet Intolerancia y Disbiosis